Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96

NCT02133079 is registered in ClinicalTrials.gov with Cure&Sure Biotech Co., LTD as lead sponsor.

NCT NCT02133079
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02133079 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96
Lead sponsor
Cure&Sure Biotech Co., LTD
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 31, 2012
Completion date
November 30, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer, pancreatic adenocarcinoma